Contact this trialFirst, we need to learn more about you.
Selective Inhibitor of Nuclear Export
KPT-330 for Relapsed Childhood Leukemia
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is for leukemia patients who have relapsed or become resistant to standard therapies. They will be given the drug KPT-330 to see if it prevents leukemia cells from growing and leads to their destruction.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.